Monthly Archives: March 2021

Hawley calls for breakup of Big Tech ‘oligarchs,’ companies that ‘sold us out to China’ – New York Post

Posted: March 3, 2021 at 1:44 am

Sen. Josh Hawley of Missouri on Friday urged fellow Republicans to support the break-up of Big Tech oligarchs that censor political viewpoints as well as large companies that sold us out to China.

Hawley called for a new nationalism that reclaims the trust-busting mantra of the Teddy Roosevelt-era GOP to fight large companies and Democrats, who he said jointly push a false message that the U.S. is systemically racist and founded on lies and evil.

We will not be told what to do by these modern-day oligarchs. What we need is a new nationalism, a new agenda to make the rule of the people real in this country, Hawley said in a speech to the Conservative Political Action Conference in Orlando, Fla.

I would start by breaking up the Big Tech corporations. Just break them up. Break them up in the name of the rule of the people, for the good of the American people and our liberty. We need to break those corporations up and cut them down to size.

Hawley cited censorship of conservatives on social media, including of former President Donald Trump following the Jan. 6 Capitol riot.

People like Google, Facebook, you heard of them? Twitter, these companies have more power than any companies in American history and theyre aligned with the radical left to try to impose their agenda on this country, he said.

They want to run this country. And if we dont do something, they are going to. And weve got a word for that. Its called oligarchy. And thats what were facing in America right now.

Hawley said the Republican Party, though long viewed as the party of business, also has a history in trust-busting recalling the Roosevelt-led charge against large companies that helped splinter the party in 1912 between factions led by Roosevelt and his successor as president, William Howard Taft.

The Republican Party, once upon a time we were the party of trustbusters, you know. I mean, we invented the concept, basically. Its time to reclaim that legacy, Hawley said.

Its time to reclaim that legacy and not just for Big Tech but for all of the huge multinational corporations that have sold us out to China, that have sold out our workers that have sold out our jobs. They need to be broken up. And we need to have free and fair competition in this country again.

Hawley said that he was unfairly attacked for objecting to certifying President Bidens electors from Pennsylvania in a bid to force a national review of voter fraud allegations.

If we cant have free and open debate in this country, were not going to have a country left, Hawley said.

If we cant have free and open debate, according to the laws in the United States Senate, what good is the United States Senate? Why do you send anybody to Washington at all? I thought it was an important stand to take. And for that the left has come after me. Theyve tried to silence me. They canceled a book a book I was writing called, The Tyranny of Big Tech. These people have no sense of irony, its still gonna get published by the way, itll be out soon.

Hawley is a leader among post-Trump conservative populists in Washington. In December he partnered with socialist Sen. Bernie Sanders of Vermont to push for $2,000 stimulus checks that were resisted by GOP Senate leaders, and on Friday he called for adoption of a $15 hourly minimum wage for companies with revenue over $1 billion.

View original post here:

Hawley calls for breakup of Big Tech 'oligarchs,' companies that 'sold us out to China' - New York Post

Posted in Big Tech | Comments Off

The internet breaks too easily. Can that be fixed? – Christian Science Monitor

Posted: at 1:44 am

Joe Browns moment of clarity came in the dark. A father and a tech enthusiast, he figured that linking his Wi-Fi enabled light bulbs to his Google Home speaker would allow him to adjust the lights with his voice while his hands were busy.

And it did, most of the time, until last December, when a Google outage rendered the lights useless. A month earlier, an outage at Amazon disabled doorbells, vacuums, and thermostats up and down the East Coast. That outage also crashed newspapers and e-commerce sites, disrupted ride-hailing and food-delivery apps, and blocked people from accessing their bank accounts.

Some services have become the central hub of most of the internet traffic, says Primavera De Filippi, a faculty associate at Harvard Universitys Berkman Klein Center for Internet & Society.

Can these single points of failure be avoided? A number of efforts are underway to help restore the decentralized network envisioned in 1989 by Tim Berners-Lee, when he created the World Wide Web. These include using mesh networking, having multiple services to use as backups, and an idea promoted by Mr. Berners-Lee himself, creating pods where users can store their personal data and control who sees it.

Joe Brown thought he had it all figured out: By installing lights compatible with his Google Home, the former Popular Science editor could control the lights in his toddlers room with his voice each morning while his hands were occupied taking care of her.

Then came the Google outage. Suddenly, Mr. Brown, who now works for Hearst Magazines, found himself unable to turn on the lights.

You rarely have a free hand when you have a baby, he says. When he found himself stuck in the dark, all he could do was laugh.

As tech companies increasingly promote the so-called Internet of Things, anything from doorbells to thermostats can be connected to the cloud. It meansconvenience but also risk,as some users discovered during a November outage at Amazon and a December outage at Google. These previously analog devices can become inoperable because of a single failure at one company miles away. So canlarge swaths of the internet, especially as justthree companiesaccount for 60% of the cloud market.

People tend to forget that clouds are just computer servers, right? So were still down to all the mechanical, all the weather, electricity, water supply, cooling [malfunctions], says Mehdi Daoudi, CEO of tech company Catchpoint.

This isnt how Tim Berners-Lee envisioned things when, in 1989, he created the World Wide Web. Despite his vision of a decentralized web for everyone, the internet has instead become dominated by a few big companies. That concentration can lead to widespread outages from single failures at Amazon or Google, and also less tangible but still pressing problems, such as concerns about data privacy and censorship. And though changing the current landscape of the internet may seem daunting, some activists and companies are willing to try.

Saying that the internet is centralized is perhaps a little bit inaccurate. Its just that some services have become the central hub of most of the internet traffic, says Primavera De Filippi, a faculty associate at Harvard Universitys Berkman Klein Center for Internet & Society. And with online activity heavily concentrated in the most dominantfirms, those giants wield enormous power, fromcontrolling users data privacy to choosing what websites to host to being the single point of success or failure for the services they run.

And basically that means we are delegating, to them, the choice, on how the platforms are run and how our data is used, she says. And they can change at any point the structure of the platform.

Mr. Browns situation might seem like a niche problem, relegated to the type of people who go for things like app-controlled vacuums. But the November and December outages are simply the latest cloud crashes that have taken large parts of the internet with them. In November, during the Amazon Web Services outage, users reported issues with everything ranging from accessing their bank and using ride-hailing services. Food delivery apps faltered, and e-commerce and newspaper websites crashed. Whenever the popular messaging service Slack goes down as it did on the first work day of 2021 companies that use it can suddenly find themselves in a position where their employees cant communicate with each other.

When it comes to surviving outages, Mr. Daoudi recommends companies having as many backups as they can afford. He noted, for example, that his company maintains multiple video-conferencing subscriptions, even though employees primarily use Zoom. He spells out a hypothetical: For a company, lets say, that has an e-commerce platform and theyre down. Well, do you have a website hosted somewhere [on a different server or cloud] that you can redirect people to to just say, Were temporarily having issues. Please come back later. Here is a coupon.?

As partial outages on the internet have been rising, bigfirms like Amazon arent sitting still.They dont want disappointed customers, and aretrying to create more robust systems.

But some people are questioning existing models. They ask: What about doing more than just surviving outages what if there was a way to challenge the primacy of large tech companies, especially when it comes to the control they have over users data?

Thats the goal of Solid, a new project from Mr. Berners-Lee, which aims to put more control of data in users hands by having users rather than tech companies or websites store their data in individually controlled pods, with others able to access limited amounts only with direct permission. Davi Ottenheimer, vice president of trust and digital ethics at Inrupt, a firm that helps create Solid-compliant commercial products, says it flips traditional data-privacy practices on their head.

One of the questions I get asked a lot is how does this change the idea that people can get information about me? Mr. Ottenheimer says. So you would give people consent to have [your] data or access to data for the purposes of a very specific thing and it doesnt get stored. If the model becomes popular enough, Mr. Ottenheimer says, eventually big tech companies will have to adapt to changing customer preferences that demand stronger data protection.

Another popular way to both secure data privacy and fight against single points of failure has been mesh networking, which at its most basic, is a network design where nodes are connected through multiple points rather than a single route. In New York, the practice has been adopted by the group NYC Mesh to create a Wi-Fi service users can connect to by installing a wireless router on their roof or balcony that connects to other nearby users. The result is an internet connection that doesnt store data, and bypasses corporate internet service providers, says organizer Brian Hall. Users are asked to set up recurring monthly donations to offset costs, in lieu of subscriptions.

The mesh networks still link people onto the regular internet, but they show that different models are possible. And if the rest of the web went dark, users of the mesh system would still have one another to be online with.

All in all, Mr. Browns outage wasnt the end of the world. He didnt feel like the methods to manually override the lights were worth the hassle, so he just carried on in the dark. And if the Google outage didnt fix itself, he would have simply put in a normal lightbulb.

Get the Monitor Stories you care about delivered to your inbox.

He hasnt sworn off smart products, either he still has the lights that temporarily failed him during the Google outage. But reflecting on some recent remodeling work he did in his kitchen, he noticed something.

I did just put some new lights in my kitchen. I wired in some new junction boxes, Mr. Brown says. And I did not connect them to the cloud.

More about Big Government than Big Tech – The Hindu

Posted: at 1:44 am

Under the IT Act new rules, it appears that the interest is largely about trying to force technologists to fall in line

Last week, the Union Government issued a set of rules under the Information Technology Act, noting that it was superseding rules issued under Section 79 of that statute in 2011. Those earlier rules had specified the due diligence obligations that Internet intermediaries had to follow in order to qualify for the limited immunity for legal liability regarding user content, which Parliament had strengthened in 2008 when it amended that law.

The notification of these new rules, however, do not merely represent the executive branch superseding previous subordinate rules under a law with newer regulation. They represent a dramatic, dangerous move by the Union Government towards cementing increased censorship of Internet content and mandating compliance with government demands regarding user data collection and policing of online services in India. This has happened in the absence of open and public discussion of the full swathe of regulatory powers the government has sought to exercise, and without any parliamentary study and scrutiny.

Editorial | A wolf in watchdogs clothing: On govts move to regulate digital media

Indeed, these rules at the outset appear unlawful even with respect to whether they could have been issued under the Information Technology Act in the manner chosen by the government, leave alone their constitutionality with respect to fundamental rights. The Union Government has chosen to pass these rules under the requirement to outline the due diligence that Internet intermediaries ranging from telecom providers, search engines, Internet platforms hosting user generated content to cloud providers have to follow in order to be able to claim their qualified legal immunity under Section 79 of the IT Act.

The governments gazette notification has further claimed that the rules were also issued under the legal authority to specific procedure for blocking web content under Section 69A of the IT Act. This is curious, given that rules overseeing government web content blocking powers have already been issued for that section in 2009, and not superseded. Indeed, they form the core of the increasing number of web content censorship orders issued by the Union Government in recent years, including the most recent controversial stand-off with Twitter following the farmer protests.

The ability to issue rules under a statute i.e. to frame subordinate legislation is by its nature a limited, constrained power. When the Union Government issues subordinate rules, it is limited to the substantive provisions laid out by Parliament in the original act passed by the latter the executive branch is subordinate to what Parliament has permitted it and cannot use its rule-making power to seek to issue primary legislation by itself.

Also read | Provision for blocking content under new IT rules not new: Centre

Unfortunately, with the present Internet content and social media rules, the Union Government has done precisely that. Instead of specifying the basic due diligence requirements intermediaries had to perform in order to make use of the Section 79 safe harbour provision, the executive branch has created new rules that apply only to significant social media intermediaries a term that appears nowhere in the Information Technology Act.

It has included mandates for retention of user data by such intermediaries for use by government agencies and clauses on how popular messaging services have to enable the tracing of the original creator of a message (which is regarded as not possible for end-to-end encrypted messaging services without introducing flaws in their systems) even though the sections in the law cited by the government do not give them that power.

In Focus Podcast | Twitter, the IT Act, and the blocking saga explained

The rules have grown to include a chapter on how digital news sites have to be registered before the Ministry of Information and Broadcasting, and further laid out a mechanism by which streaming video sites featuring original content (which are generally not regarded as intermediaries for the purposes of Internet law) have to agree to a government-supervised self regulatory system. This, even though digital news service registration is not required under the IT Act and streaming video content has not been included under the ambit of the Cinematograph Act. In any other situation, the package contained in this gazette notification last week would be instead included in a bill sent to Parliament for its consideration and which would be regarded as ambitious and controversial for any administration.

Why has the Union Government created this legally uncertain, sprawling house-of-cards-like regulatory instrument? To understand these new Internet content control rules for that is what they essentially are you need to not only see what they directly give to the government, but what the government is seeking to get done behind a shadow of regulatory pressure. It appears that the government wants to send a message to all Internet ecosystem players that they desire compliance with their desires formal or informal regarding what content should be taken down, along with a removal of any push back against over broad demands for user data and other surveillance orders by government agencies.

Comment | Should governments regulate online platforms?

The Government of India already has significant legal powers, with practically no institutionalised oversight or true checks and balances, to force censorship and surveillance on Internet platforms and other web services in India.

However, the increasing public discussion of concerns regarding the usage of these powers and challenges being made by firms and impacted individuals against their abuse is something that the Union Government would like to avoid. Why issue direct formal orders when one can instead force compliance in less visible, more institutionalised ways? Indicating that the government has made up its mind to force these mandates by notifying them, even with doubtful legal validity, is a key signalling effect to Internet ecosystem players, especially firms keen to avoid public battles and smaller entities who do not have the resources or political position to be able to contest overboard government directives.

In Focus podcast | Will regulation of digital media lead to an era of government censorship?

The Union Government, when issuing these rules, made reference to increased global interest in regulating Big Tech. However, in advancing Internet content control interests and increased requirements around government demands for user data, while not advancing surveillance law reform or enacting a strong statutory data protection framework, it appears that the interest is more in advancing Big Government and trying to force technologists to fall in line, no matter the cost to our fundamental rights in our Internet age.

Raman Jit Singh Chima is Senior International Counsel and Asia Pacific Policy Director, Global Cybersecurity Lead, Access Now

This story is available exclusively to The Hindu subscribers only.

Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.

Enjoy reading as many articles as you wish without any limitations.

A select list of articles that match your interests and tastes.

Move smoothly between articles as our pages load instantly.

A one-stop-shop for seeing the latest updates, and managing your preferences.

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

Original post:

More about Big Government than Big Tech - The Hindu

Posted in Big Tech | Comments Off

Ageless Review: The Long Run – The Wall Street Journal

Posted: at 1:43 am

On arriving in London to seek his fortune, the rambunctious Scottish physician George Cheyne set about hobnobbing in coffee houses and taverns, where he ate lustily and swallowed down much liquor. Before long, he had ballooned to nearly 450 pounds. In a state of existential crisis and discerning that his mortality was in the balance, he published a self-help manual, An Essay of Health and Long Life (1724). In this bestselling treatise, he singled out tea, coffee, chocolate and snuff as being especially detrimental to the human condition.

This seminal work, among others, spawned a tradition of books addressing the topic of longevity which continues to this day. While Cheyne and others contrived innumerable methods designed to maintain good health and extend lifespans, the process of aging has itself invariably been viewed as an immutable part of human nature.

No longer, says Andrew Steele in his entertaining and thoughtful book Ageless (Doubleday, 352 pages, $29). While we wither and become frail after a mere seven or so decades, the humble Galpagos tortoise bumbles on healthily into a 175-year dotage. Capturing this traitknown as negligible senescenceis the holy grail of aging research.

So if, as Mr. Steele contends, tortoises get old without getting elderly, might we not master biological immortality and become ageless too? Were this achievable, the existence of a bristlecone pine tree in Californias White Mountains, estimated to be an extraordinary 4,850 years old, suggests that such potential extensions to our longevity might be more than mere tweaks. The fact that lifespans of different species vary so greatlysome mayflies emerge, mate and die within 5 minutes, while bowhead whales can live for more than 200 yearsindicates that our lifespan is programmed by evolution, rather than restricted by insurmountable constraints.

Ageless follows biologist George C. Williamss simple evolutionary explanation for why we age, based on a phenomenon called antagonistic pleiotropy. Put simply, genes selected to facilitate early successful reproduction may have detrimental effects as we get older. In Mr. Steeles words, it looks as if evolution has traded our future health for increased reproduction. Were we able to roll the clock back and redesign ourselves, we would doubtless find alternative genetic circuits that did not have these unfortunate consequences. Perhaps one day, Mr. Steele conjectures, we will be able to reprogram our genomes to remove this legacy. Fortunately, there may be more immediately accessible paths to a longer life.

Originally posted here:
Ageless Review: The Long Run - The Wall Street Journal

Posted in Human Longevity | Comments Off

Immigration Bill Shows Need To End Employment-Based Immigrant Backlog – Forbes

Posted: at 1:43 am

High-skilled foreign nationals, including doctors and engineers, rally on Capitol Hill in ... [+] Washington, D.C., to protest long delays in getting green cards on September 18, 2007, in Washington, D.C. The employment-based green card backlog has worsened since 2007. (Photo by Jahi Chikwendiu/The Washington Post via Getty Images)

Without a change in immigration law, it will be sometime in the year 2216195 years from nowwhen the last person born in India waiting today in the employment-based immigrant backlog is expected to receive a green card. Barring advances in human longevity, businesses and high-skilled foreign nationals must rely on Congress to solve this problem and enact reasonable policies to welcome highly skilled people who want to become Americans.

The Scope of the Problem: H-1B and L-1 (intracompany transferee) are temporary statuses, meaning if someone wishes to remain in the United States, they must obtain an employment-based immigrant visa (or green card) that grants permanent residence. However, there is far greater demand for high-skilled individuals than the limited number of employment-based green cards allotted by Congress.

Since 1990, when Congress set the annual limit on employment-based immigrants at 140,000 (and 65,000 H-1B temporary visas), changes in technology have accelerated the demand for high-skilled technical labor. Congress established the current employment-based limits before the internet became a part of daily life. It also predates the iPhone, the iPad, YouTube, e-commerce, Netflix, Google, cloud computing and thousands of innovative companies and technologies that have come into existence and fueled the demand for high-skilled labor.

U.S. businesses would still need more scientists and engineers to grow and innovate even if the number of Americans earning degrees in science and engineering had explodedand it hasnt.

Between 1995 and 2015, full-time U.S. graduate students in electrical engineering decreased by 17%. The number of full-time U.S. graduate students in computer science increased by 45% from 1995 to 2015, while international graduate students increased by over 480%. (H-1B visa fees paid by employers have funded approximately 100,000 college scholarships for U.S. students in science and engineering.)

As of March 2020, the backlog in EB-1, EB-2 and EB-3the employment-based first, second and third preferenceswas 915,497, according to the Congressional Research Service (CRS).

Without Congressional action, notes CRS, the problem will grow worse: The total backlog for all three categories would increase from an estimated 915,497 individuals currently to an estimated 2,195,795 individuals by FY 2030.

Let that number sink in: Within a decade, more than 2 million people will be waiting in line, most for many years or even decades, for employment-based green cards. And there are indications this underestimates the problem.

Table 1 shows that in FY 2018 only about 4,500 Indians obtained permanent residence in the employment-based second preference and fewer than 6,000 received green cards in the employment-based third preference. (The National Foundation for American Policy obtained the data via a Freedom of Information Act request.)

CRS estimates the annual demand for employment-based green cards in the three preference categories is 262,376 (including dependents). This is based on petitions U.S. Citizenship and Immigration Services (USCIS) approved in FY 2018. CRS explains the backlog grew because there is a current limit of 120,120 green cards for the three employment-based immigration categories.

Another problem is that Congress established a per-country limit of 7% for each country that burdens mainly potential employment-based immigrants from India but also affects people born in China and the Philippines. The law, in effect, gives the same number of green cards for employment to India as it does Iceland.

In the employment-based second preference (EB-2): Under current law, and owing to a limited number of green card issuances, the current backlog of 568,414 Indian nationals would require an estimated 195 years to disappear, according to CRS. David Bier of the Cato Institute predicts about 186,038 Indian immigrants will die . . . before they receive green cards even if they could remain in line forever.

By FY 2030, [the] estimated wait time would more than double, according to CRS. Under S. 386, the estimated wait time for newly approved EB-2 petition holders would shrink to 17 years, and in FY 2030, the wait time would be 37 years, the same as for all other foreign nationals.

S. 386 was a bill in the last Congress sponsored by Sen. Mike Lee (R-UT) that would have eliminated the per-country limit for employment-based immigrants. Rep. Zoe Lofgren (D-CA) wrote H.R. 1044 with Rep. Ken Buck (R-CO) and it passed the House in July 2019. The companion bill, S. 386, was blocked in the Senate for more than a year. It became a Christmas tree for extraneous immigration provisions. The Senate finally approved S. 386 near the end of the session but the House found the provisions to be objectionable and it did not become law. The bill would not have increased the number of employment-based green cards but would have reduced the wait times for those waiting the longest for permanent residence, particularly professionals from India.

Without any change in the law, CRS predicts: Currently, new Indian beneficiaries entering the EB-3 [employment-based third preference] backlog can expect to wait 27 years before receiving a green card. (The wait time would be much longer in the EB-2 category.)

Scientists and engineers waiting for their green cards may see their children who have lived in the United States for years be forced to leave the country when they age out of their place on a mother or fathers immigration application when reaching 21 years old. USCIS policies during the Trump administration caused many spouses of H-1B visa holders waiting for green cards to lose their work authorization due to long processing delays.

New Immigration Bill Would End the Employment-Based Backlog: The U.S. Citizenship Act, developed by the Biden administration, would eliminate the employment-based backlog within 10 years through various provisions, according to a National Foundation for American Policy (NFAP) analysis.

First, the bill would no longer count spouses and children toward the annual limit, which would approximately double the annual number of employment-based green cards. Second, the legislation increases the annual limit for family-sponsored immigrants and allows unused numbers from the family categories to be used by the employment categories. That means once the family backlog is eliminated, which NFAP predicts could happen within 5 or 6 years, backlog reduction in the employment-based categories would accelerate.

Third, the bill eliminates the per-country limit. Fourth, the legislation allows unused green cards from earlier years to be redirected to reduce family and employment backlogs.

The bill also contains a provision, which NFAP has recommended, to allow any individuals who wait at least 10 years with an approved immigrant petition to receive permanent residence without numerical limit. If Congress passed only this reform, it would help many people and bring certainty to otherwise interminable waits for many employment-based immigrants.

Related to the backlog, in its final days, the Trump administration published a final rule designed to price employment-based immigrants and H-1B visa holders out of the U.S. labor market. The regulation would boost required wages 23% to 41% depending on the occupation, according to an NFAP study. The regulation could block people waiting for green cards if the new required salary is too high for an employer to retain them in H-1B status. (Individuals can be extended in H-1B status while waiting for an employment-based green card.)

If the Biden administration keeps the rule, it would be a significant victory for former White House adviser Stephen Miller and opponents of immigration.

Numerous studies and private wage surveys show that there is no evidence high-skilled foreign nationals are paid less than comparable U.S. professionals. If employers were forced to pay high-skilled immigrants 41% more than comparable U.S. workers, one would expect critics would still claim the immigrants were paid less because that is typically the only argument put forward against high-skilled foreign nationals who work in America. Members of Congress are repeatedly told to believe the only value someone born in another country offers a U.S. business or the U.S. economy is a willingness to work for less money.

If we have learned one thing from the pandemic, it is how valuable immigrants are to America. Immigrants play key roles in the two companies responsible for the Covid-19 vaccines Americans are receiving to protect their lives. Modernas leaders, two cofounders and critical scientific personnel are immigrants, as are the chief executive (and chief science officer) of Pfizer and a key scientist (Katalin Karik) who made a crucial breakthrough on messenger RNA, as noted in a December 2020 article. Even the founders of Pfizer were immigrants.

We have blown the opportunity to maximize the incredible high-skilled immigrants in this country, said Sen. Kevin Cramer (R-ND) at a recent hearing. The backlog of green cards is immoral to me. Will this be the year moral outrage and economic sense lead to a solution for employment-based immigrants?

See the original post here:
Immigration Bill Shows Need To End Employment-Based Immigrant Backlog - Forbes

Posted in Human Longevity | Comments Off

Anti-Senescence Therapy Market Report Research Reports, Industry Size, In-Depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis…

Posted: at 1:43 am

Anti-Senescence Therapy Market 2021: Latest Analysis

Los Angeles, United State,March 2021, The study published on the Anti-Senescence Therapy market is a systematic review that includes key parameters and indicators that are crucial to market understanding. The data from the years 2015 to 2020 is used to show the status and size of the market. The report also includes a total market value for the forecast period, along with the CAGR. The introductory chapter, along with the product description and market scope, provides an overview of the Anti-Senescence Therapy industry. The study also analyzes market dynamics in product-related matters along with developments in the growth of the industry.

Anti-Senescence Therapy Market 2021 Research report contains a qualified and in-depth examination of Anti-Senescence Therapy Industry. At first, the report provides the current business situation along with a valid assessment of the Anti-Senescence Therapy Market Analysis. This report is partitioned based on driving Anti-Senescence Therapy Market Top Key players, application and regions. The progressing Anti-Senescence Therapy economic situations are additionally discovered in the report.

Major Key Manufacturers ofAnti-Senescence Therapy Market are:Unity Biotechnology, OisinBiotechnologies, AgeX Therapeutics, Siwa Therapeutics, Cleara Biotech, Calico, Sierra Sciences, Human Longevity (HLI), Numeric Biotech, Recursion Pharmaceuticals, Proteostasis Therapeutics, Senolytic Therapeutics, Allergan

Request Free Sample Reportwith Complete TOC and Figures & Graphs@https://www.mraccuracyreports.com/report-sample/205864

Market Segment by Type covers:Gene Therapy, Immunotherapy, Others

Market Segment by Applications can be divided into:Unity Biotechnology, OisinBiotechnologies, AgeX Therapeutics, Siwa Therapeutics, Cleara Biotech, Calico, Sierra Sciences, Human Longevity (HLI), Numeric Biotech, Recursion Pharmaceuticals, Proteostasis Therapeutics, Senolytic Therapeutics, Allergan

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Anti-Senescence Therapy market.

Production, consumption, revenue, market share, and growth rate are the key targets forAnti-Senescence Therapy Market forecast from 2013 to 2026 (forecast) in these regions:

Benefits of buying the report:

Impact Of COVID-19

The most recent report includes extensive coverage of the significant impact of the COVID-19 pandemic on theAnti-Senescence Therapy division. The coronavirus epidemic is having an enormous impact on the global economic landscape and thus on this special line of business. Therefore, the report offers the reader a clear concept of the current scenario of this line of business and estimates the aftermath of COVID-19.

You can buy the complete report@ https://www.mraccuracyreports.com/checkout/205864

There are 15 Chapters to display the Global Anti-Senescence Therapy market

Chapter 1, Definition, Specifications and Classification of Anti-Senescence Therapy, Applications of Anti-Senescence Therapy, Market Segment by Regions;Chapter 2, Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;Chapter 3, Technical Data and Manufacturing Plants Analysis of Anti-Senescence Therapy, Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis;Chapter 4, Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);Chapter 5 and 6, Regional Market Analysis that includes United States, China, Europe, Japan, Korea & Taiwan, Anti-Senescence Therapy Segment Market Analysis (by Type);Chapter 7 and 8, The Anti-Senescence Therapy Segment Market Analysis (by Application) Major Manufacturers Analysis of Anti-Senescence Therapy ;Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type Gene Therapy, Immunotherapy, Others, Market Trend by Application Unity Biotechnology, OisinBiotechnologies, AgeX Therapeutics, Siwa Therapeutics, Cleara Biotech, Calico, Sierra Sciences, Human Longevity (HLI), Numeric Biotech, Recursion Pharmaceuticals, Proteostasis Therapeutics, Senolytic Therapeutics, Allergan , Others;Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;Chapter 11, The Consumers Analysis of Global Anti-Senescence Therapy ;Chapter 12, Anti-Senescence Therapy Research Findings and Conclusion, Appendix, methodology and data source;Chapter 13, 14 and 15, Anti-Senescence Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

GetExclusive Discount on this report @https://www.mraccuracyreports.com/check-discount/205864

About us:

MR Accuracy Reportsprovides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Email:[emailprotected]

Website:www.mraccuracyreports.com

See the original post here:
Anti-Senescence Therapy Market Report Research Reports, Industry Size, In-Depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis...

Posted in Human Longevity | Comments Off

4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management Team – BioSpace

Posted: at 1:43 am

LEEDS, England--(BUSINESS WIRE)-- 4D Pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the appointment of John Beck as Chief Financial Officer (CFO) and member of the Companys management team, bringing over 30 years of experience in finance, including three previous positions as Chief Financial Officer of publicly traded life sciences companies.

John will be an important addition to 4D pharmas management team at such a pivotal time, as the company prepares to close our SPAC merger and begin trading on NASDAQ. His deep experience and financial expertise as a CFO of several publicly traded life sciences companies will be critical as we further grow our company and global footprint, said Duncan Peyton, Chief Executive Officer of 4D pharma.

John Beck brings over 30 years of experience in financial and biopharmaceutical industry management experience. This includes three previous positions as Chief Financial Officer of publicly traded life sciences companies where he has achieved considerable results in areas including finance, business and corporate development, strategy, and commercialization.

I look forward to contributing the success of 4D pharma at this exciting stage in its development. 4Ds pioneering work to develop promising therapies across a number of disease areas from oncology to the gut-brain axis is clearly differentiated through its MicroRx platform and LBP product candidates, said John Beck, Chief Financial Officer of 4D pharma. With several key data readouts upcoming and our potential listing on NASDAQ, I believe 4D is well positioned to expand and enhance its investor base and drive further shareholder value for the remainder of 2021.

Mr. Beck has extensive investor and public relations, corporate governance, regulatory, and fundraising expertise. Most recently he was the Senior Vice President, Finance and CFO of Ritter Pharmaceuticals from May 2018 to May 2020, where he oversaw its successful merger with Qualigen Therapeutics, Inc. Prior to that, Mr. Beck served as Executive Manager and CEO at Wellspring Water Technologies, LLC and CEO of West Tech Medical, LLC from October 2015 to May 2018. Mr. Beck also was the CFO and Senior Vice President of Finance and Operations of Ardea Biosciences from February 2008 to June 2012, where he raised over $160 million in public financings, executed a $400 million out-licensing transaction with Bayer Pharmaceuticals and completed a $1.2 billion merger with AstraZeneca. Mr. Beck also held positions as Senior Vice President of Finance, Treasurer and CFO of Metabasis Therapeutics, and the Director of Finance at Neurocrine Biosciences, leading both through successful NASDAQ IPOs.

In addition, Mr. Beck currently serves on the Board of Directors of San Diego-based Artelo Biosciences, as a scientific advisor and mentor to the University of San Diegos student-run TRITON fund. Mr. Beck holds a B.A. in Accounting from the University of Washington, Seattle, a degree in theology from a Seattle area seminary and is a licensed CPA (inactive status) in the state of California.

About 4D pharma

Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.

4D pharma's Live Biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut. The Company has six clinical programs, namely a Phase I/II study of MRx0518 in combination with KEYTRUDA (pembrolizumab) in solid tumors, a Phase I study of MRx0518 in a neoadjuvant setting for patients with solid tumors, a Phase I study of MRx0518 in patients with pancreatic cancer, a Phase I/II study of MRx-4DP0004 in asthma (NCT03851250), a Phase II study of MRx-4DP0004 in patients hospitalized with COVID-19 (NCT04363372), and Blautix in Irritable Bowel Syndrome (IBS) (NCT03721107) which has completed a successful Phase II trial. Preclinical-stage programs include candidates for CNS disease such as Parkinson's disease and other neurodegenerative conditions. The Company has a research collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics for vaccines.

In October 2020 4D pharma announced its intention to merge with Longevity Acquisition Corporation (NASDAQ: LOAC), a special purpose acquisition company (SPAC), and seek a NASDAQ listing. The merger is expected to be completed and the NASDAQ listing of 4D pharma American Depositary Shares (ADSs) under the ticker symbol 'LBPS' is currently expected to become effective in early 2021, subject to the satisfaction of closing conditions, including approval of 4D shareholders and Longevity shareholders and the approval by Nasdaq of the listing of ADSs.

For more information, refer to http://www.4dpharmaplc.com.

Forward-Looking Statements

This press release contains "forward-looking statements." All statements other than statements of historical fact contained in this announcement, including without limitation statements regarding timing of the clinical trial are forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the United States Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements are often identified by the words "believe," "expect," "anticipate," "plan," "intend," "foresee," "should," "would," "could," "may," "estimate," "outlook" and similar expressions, including the negative thereof. The absence of these words, however, does not mean that the statements are not forward-looking. These forward-looking statements are based on the Company's current expectations, beliefs and assumptions concerning future developments and business conditions and their potential effect on the Company. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting the Company will be those that it anticipates.

All of the Company's forward-looking statements involve known and unknown risks and uncertainties, some of which are significant or beyond its control, and assumptions that could cause actual results to differ materially from the Company's historical experience and its present expectations or projections. The foregoing factors and the other risks and uncertainties that affect the Company's business, including the risks of delays in the commencement of the clinical trial and those additional risks and uncertainties described the documents filed by the Company with the US Securities and Exchange Commission (SEC), should be carefully considered. The Company wishes to caution you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to publicly update or revise any of its forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required by law.

Additional Information about the Transaction and Where to Find it

This press release is being made in respect of a proposed business combination involving 4D and Longevity. Following the announcement of the proposed business combination, 4D filed a registration statement on Form F-4 (the Registration Statement) with the SEC which was declared effective on February 25, 2021. This press release does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities or a solicitation of any vote or approval nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The Registration Statement includes a prospectus with respect to 4Ds ordinary shares and ADSs to be issued in the proposed transaction and a proxy statement of Longevity in connection with the merger. The proxy statement/prospectus has been mailed to the Longevity shareholders on or about February 26, 2021. 4D and Longevity also plan to file other documents with the SEC regarding the proposed transaction.

This press release is not a substitute for any prospectus, proxy statement or any other document that 4D or Longevity may file with the SEC in connection with the proposed transaction. Investors and security holders are urged to read the Registration Statement and, when they become available, any other relevant documents that will be filed with the SEC carefully and in their entirety because they will contain important information about the proposed transaction.

You may obtain copies of all documents filed with the SEC regarding this transaction, free of charge, at the SECs website (www.sec.gov). In addition, investors and security holders will be able to obtain free copies of the Registration Statement and other documents filed with the SEC without charge, at the SECs website (www.sec.gov) or by calling +1-800-SEC-0330.

Participants in the Solicitation

Longevity and its directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies from Longevitys shareholders with respect to the proposed transaction. Information regarding Longevitys directors and executive officers is available in its annual report on Form 10-K for the fiscal year ended February 29, 2020, filed with the SEC on April 30, 2020. Additional information regarding the participants in the proxy solicitation relating to the proposed transaction and a description of their direct and indirect interests is contained in the Registration Statement.

4D and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of Longevity in connection with the proposed transaction. A list of the names of such directors and executive officers and information regarding their interests in the proposed transaction is included in the Registration Statement.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210301005053/en/

Original post:
4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management Team - BioSpace

Posted in Human Longevity | Comments Off

As Black Women, We Need to Save Ourselves, Not the World – Healthline

Posted: at 1:43 am

Its time to stop mythologizing Black women trying to survive in a world that doesnt value them.

Content warning: police violence, Black death

Black women arent your superheroes. We arent selfless vigilantes, watching through the night for signs of trouble. Were not perched on the wings of the city, waiting to swoop in and save white people in distress.

Black women are human amazing, creative, self-sacrificing humans but human nonetheless. We save others to save ourselves.

But continual demands on Black women to act while others do nothing is killing us.

The last 12 months of nonstop political and cultural turmoil a pandemic, constant images of police brutality, contested elections, insurrection have only further proven how invaluable Black women are to society.

These recent affairs have produced countless examples of Black women turned into superhero caricatures by the white gaze; white people are obsessed with us, obsessed with what we can do for them.

Amanda Gorman, the Youth Poet Laureate who spoke at President Bidens inauguration, has been portrayed as a larger-than-life superhero, a magical being meant to save the United States from itself.

Stacey Abrams (with a coalition of other Black women) helped expand voter accessibility in Georgia. Shes being painted as an almost fanciful champion, saving marginalized votes from the evil clutches of voter suppression tactics without so much as breaking a sweat.

Black women, as a collective, helped the Democratic Party crawl to victory in the 2020 presidential election.

Dont get it twisted; these Black women are wholeheartedly brilliant full stop but white people have mythologized them.

Black women have gone from attentive citizens participating in democracy to protect their communities interests to Americas safety net. Shine the Bat-Signal and well be there in 5.

Beyond establishment politics, Black women are also at the front lines of revolutionary work, slaying systems that disproportionately execute Black people.

Black women have led the months of protests, calling for reverence toward Black life (long after supposed white allies fell to the wayside).

Were the ones creating and circulating calls to action. Were the ones making posters for protests. Were the ones giving our time and energy to various marches and rallies.

Black women do the bulk of organizing, leading, and participating in these revolutionary moments as others stand aside and contribute little beyond pledges to do better.

We save democracies. We save our people. All while juggling personal responsibilities and bearing the cross of what it means to be a Black woman in the world.

And yet, despite the deep and abundant ways that Black women serve everyone, no one shows up for us. No one thanks us for the labor we do at least not in any meaningful way.

No one cares about our constant exhaustion given the trauma and pain we carry and what it does to us physically, emotionally, and mentally.

When it comes to opportunities to show up for us and with us, people rarely find the time. Theyre lackluster about showing any solidarity or support for us; the dedication isnt reciprocated.

Historically, movements like first-wave feminism pushed out Black women in fear that our calls for humanity would weaken the overall movement. Even as Black trans women led the queer liberation movement of the 1960s and 70s, their critical involvement is routinely forgotten.

Currently, rallies for #SayHerName have notably fewer attendants. In fact, the hashtag we created to highlight our unique plight has been co-opted and misused, silencing our message.

Vigils honoring Black trans women are quietly circulated and sparsely attended.

Instead of celebrating the work Black women do and the investments we constantly make in others, the world harms us. The world hates us. The world finds new and innovative ways to humiliate, degrade, and commit violence upon us.

People especially white people who self-consciously tweet about thanking Black women use Black women as a steppingstone to continue living a life of ignorant bliss and placidity.

Despite our cultural and political climate demanding that people finally respect the fullness and beauty of Black life, people still find it in their chest to disrespect and dehumanize Black women.

The killings of Breonna Taylor, Nina Pop, and countless other Black women show how disposable we are.

The fact that the officer who killed Breonna Taylor was punished for wanton endangerment (for the bullets that hit a neighboring apartments walls) versus the bullets that sliced through Breonnas body shows how little Black women matter.

Charges were brought for endangering human life as if Breonnas life wasnt snatched without hesitation. Let this sentencing and others without a flake of justice show how Black women are regarded in this life.

Black women are the victims of all kinds of violence.

The violence looks like being categorically harassed on Twitter by all different races of men.

The violence looks like Talib Kweli dedicating hours upon hours of tweeting to harass Maya Moody, a Black woman whom he had a disagreement with.

The violence looks like Black women being disproportionately affected by and dying from domestic violence.

The violence looks like the epidemic of Black trans women being murdered.

The violence looks like Megan Thee Stallion being shot by Tory Lanez and having her fellow music industry colleagues stay silent about her abuse. It looks like people mocking her trauma, calling her a snitch, and making jokes at her expense.

These types of hate and vitriol are specifically reserved for us.

Our physical and mental health is impaired as people stand around and watch us suffer.

Black women are disproportionately affected by mental health conditions like anxiety, having more intense and chronic symptoms compared with our white counterparts.

Our physical pain is routinely downplayed and undertreated by white doctors.

Black women also have a higher risk of developing and dying from illnesses such as heart disease and cancer.

Were often told these health disparities stem from lifestyle factors, despite research that says otherwise.

Our bodies are literally being worn down by the stress we face, further proving that the lived reality of Black women isnt just a trendy political discussion point. Its an all too real public health crisis that erodes at our very being.

The way that the United States continually burdens Black women with its demands for our intelligence, our sympathy, our action, and our myriad other talents, all the while ignoring our well-being and humanity, is a problem.

Its an issue thats literally killing us. As Black women, we have a responsibility to ourselves to practice self-care and preservation. Of course, the practical ability to do this is difficult considering every crisis that plagues anyone will befall us 10 times worse.

Whenever possible, though, we need to draw boundaries and put ourselves first.

And the wave of people who shower us with empty thanks on social media while doing nothing material to protect our welfare also have a responsibility. Simply put: You all need to legitimately and unquestionably ride for us.

You need to give your money to Black women who are on the front lines. You need to give your money to Black women who move through the world, simply trying to survive.

You need to use your platform to decry the injustices Black women suffer, who die at the hands of misogynoir.

You need to listen to Black women, when we tell you we are hurting, when we tell you that you are hurting us.

You need to examine and unlearn your assumptions about what Black women do and do not owe you (spoiler alert: we owe you nothing).

You need to stop treating us like your emergency brake, as if were only placed on this earth to serve.

Black women deserve to experience the fullness of life without being run ragged by the demands of others.

We should be able to live with some dignity without fearing violence or a premature death because of what the world does to us.

Everyone absolutely everyone has a part to play in ensuring that Black women are protected and showing us that we matter.

Gloria Oladipo is a Black woman and freelance writer, musing about all things race, mental health, gender, art, and other topics. You can read more of her funny thoughts and serious opinions on Twitter.

More here:
As Black Women, We Need to Save Ourselves, Not the World - Healthline

Posted in Human Longevity | Comments Off

Aligning the social pillar with human rights – Social Europe

Posted: at 1:43 am

The Action Plan of the European Pillar of Social Rights could lead to a profound shift in the enjoyment of human rights in the EU.

The pandemic and the measures taken to combat it have upended many lives. For millions around the world, Covid-19 has brought protracted uncertainty, isolation and hardship, with no end in sight.

The global poverty rate is likely to increase for the first time in 20 years, risking the reversal of substantial gains. The United Nations secretary-general, Antnio Guterres, has called for a global reset as the world continues to reel from the pandemic, which has claimed more than two million lives and some 500 million jobs.

In Europe, the detrimental impact on the right to physical and mental health has been compounded by over-reliance on the institutional care of older persons and persons with disabilities. And those already in a precarious situation have been hit hardest, with women and minorities particularly afflicted.

At the beginning of last week, the Council of the EU adopted conclusions on a human-rights-based post-Covid-19 recovery, restating the indivisibility of all human rights and reaffirming that a socio-economic response with human rights at its core would enable a more sustainable recovery and make systems more resilient to future shocks. A week earlier, in a joint communication on multilateralism from the European Commission and the high representative for foreign affairs and security policy, the EUs commitment to human rights was presented not only as a matter of values but as an essential component of its support for a rules-based international order.

But the commitment must start at homewith a human-rights-based approach to the Action Plan, due tomorrow, to implement the European Pillar of Social Rights agreed in 2017.

"Social Europe publishes thought-provoking articles on the big political and economic issues of our time analysed from a European viewpoint. Indispensable reading!"

Columnist for The Guardian

Thank you very much for your interest! Now please check your email to confirm your subscription.

Expectations are high for the Action Planfor improving working conditions, tackling homelessness and enhancing social protection. Rightly so, because the pandemic has created an unprecedented opportunity for the EU to trigger a seismic shift in the enjoyment of social rights in the union.

An approach that places human beings and their rights at its centrenot as passive recipients of services but as rights-holders with agencyis the only route to a sustainable recovery. The plan should be guided by international human-rights treaties and recommendations, as well as the UNs 2030 Agenda for Sustainable Development.

While states, as primary duty-bearers under international law, carry the main responsibility to respect, protect and fulfil social rights, the role of the EU institutions cannot be overstated. A rights-based approach will not only help close protection gaps for people living in Europe; it will also strengthen coherence among international, regional and national systems and enhance legal certainty for member states and domestic courts.

But this is about more than compliance: international human rights can sharpen the effectiveness of policy interventions. In addition to the EUs own tools, such as the Social Scoreboard, the findings of UN treaty bodies establish a useful baseline as to where countries stand in terms of social rights. As parties to the UN Convention on Economic, Social and Cultural Rights, member states are, after all, bound to implement these norms. In this vein, the Action Plan should also explicitly recognise adequate housing and social protection as matters of human rightsnot as a commodity or as services.

As you may know, Social Europe is an independent publisher. We aren't backed by a large publishing house or big advertising partners. For the longevity of Social Europe we depend on our loyal readers - we depend on you. You can support us by becoming a Social Europe member for less than 5 Euro per month.

Thank you very much for your support!

It is precisely at this time of crisis that solid public participation is needed. Rights-holders should be enabled to participate effectively in the implementation and review of the social pillarespecially representatives of the most marginalised. To collect reliable information on who they are, the Action Plan should call on states to collect data on socio-economic status, disaggregated by age, sex, race/ethnicity, national origin, disability, education and property.

Because of their proximity to the citizen, local and regional authorities should be more involved in formulating policy. Their views on what works and what doesnt, in healthcare, housing or employment, including job creation, are critical to designing and implementing policies that work for all.

Clear quantitative and qualitative targets should be set and accompanied by a robust system to measure results. Indicators already exist to track and assess progresson human rights from the UN Human Rights Office plus those associated with the Sustainable Development Goals. The Action Plan should also envisage transparent and publicly accessible tools to track linked financial allocations and expenditures.

The EU and its member states have been the strongest supporters of national human-rights institutions around the world and should systematically bring them on board in the Action Plan. National human-rights institutions are state-mandated bodies, independent of government, which advise on legislation, monitor human-rights compliance, raise public awareness and help individuals claim their rights. They also act as a bridge to the international human-rights system.

By aligning its internal policies with its vision for external action, as also articulated in the EU Action Plan for Human Rights and Democracy, Europe can lead by example. But internal coherence will also be central to the plans success. Hence, the importance of joined-up implementation with various other EU policies seeking to advance economic and social rights: the Disability Strategy, the Anti-Racism Action Plan, the Gender Equality Strategy, the Child Guarantee, the Youth Guarantee, the Strategic Framework on Roma Equality and Inclusion, and the LGBTI+ Equality Strategy.

We have before us a chance to close serious gaps in the enjoyment of social rights across the region. If this opportunity is seized, it will lead to better and tangible outcomes in the Covid-19 recovery andmost importantlywill guarantee a life of greater dignity for all.

Go here to see the original:
Aligning the social pillar with human rights - Social Europe

Posted in Human Longevity | Comments Off

4D Pharma Announces US SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ -…

Posted: at 1:43 am

Feb. 26, 2021 07:00 UTC

LEEDS, England--(BUSINESS WIRE)-- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces that the United States Securities and Exchange Commission (SEC) has declared effective its registration statements on Form F-4 with respect to the issuance of 4D pharma American Depositary Shares (ADSs) to the shareholders of Longevity Acquisition Corporation (NASDAQ: LOAC) (Longevity), a NASDAQ-listed special purpose acquisition company (SPAC), in connection with the previously announced merger between 4D pharma and Longevity.

It is expected that 4D pharma ADSs will begin trading on NASDAQ under the ticker symbol LBPS following completion of the merger, subject to the satisfaction of the conditions to closing in the merger agreement between 4D pharma and Longevity, including approvals of 4D pharma and Longevity shareholders.

As reported in October 2020, the registration statement facilitates the creation of a trading market in the US for ADSs representing the Company's Ordinary Shares. 4D pharmas Ordinary Shares will continue to be admitted to trading on AIM, a market operated by the London Stock Exchange, under the current ticker symbol DDDD.

The Company will send a circular to 4D pharma shareholders in due course in order to convene a General Meeting to, inter alia, approve the merger.

About 4D pharma

4D pharma's Live Biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut. The Company has six clinical programmes, namely a Phase I/II study of MRx0518 in combination with KEYTRUDA (pembrolizumab) in solid tumours, a Phase I study of MRx0518 in a neoadjuvant setting for patients with solid tumours, a Phase I study of MRx0518 in patients with pancreatic cancer, a Phase I/II study of MRx-4DP0004 in asthma, a Phase II study of MRx-4DP0004 in patients hospitalised with COVID-19, and Blautix in Irritable Bowel Syndrome (IBS) which has completed a successful Phase II trial. Preclinical-stage programmes include candidates for CNS disease such as Parkinson's disease and other neurodegenerative conditions. The Company has a research collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics for vaccines.

In October 2020 4D pharma announced its intention to merge with Longevity Acquisition Corporation (NASDAQ: LOAC), a special purpose acquisition company (SPAC), and seek a NASDAQ listing. The merger is expected to be completed and the NASDAQ listing of 4D pharma American Depositary Shares (ADSs) under the ticker symbol LBPS is currently expected to become effective in early 2021, subject to approval of 4D Shareholders and Longevity Shareholders.

For more information, refer to https://www.4dpharmaplc.com

Forward-Looking Statements

This press release contains "forward-looking statements." All statements other than statements of historical fact contained in this announcement, including without limitation statements regarding expected trading of 4D pharma ADSs on NASDAQ and the potential timing thereof, are forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the United States Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements are often identified by the words "believe," "expect," "anticipate," "plan," "intend," "foresee," "should," "would," "could," "may," "estimate," "outlook" and similar expressions, including the negative thereof. The absence of these words, however, does not mean that the statements are not forward-looking. These forward-looking statements are based on the Company's current expectations, beliefs and assumptions concerning future developments and business conditions and their potential effect on the Company. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting the Company will be those that it anticipates.

All of the Company's forward-looking statements involve known and unknown risks and uncertainties, some of which are significant or beyond its control, and assumptions that could cause actual results to differ materially from the Company's historical experience and its present expectations or projections. The foregoing factors and the other risks and uncertainties that affect the Company's business, including the risks of delays in admitting the ADSs to trading on NASDAQ and those additional risks and uncertainties described the documents filed by the Company with the US Securities and Exchange Commission (SEC), should be carefully considered. The Company wishes to caution you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to publicly update or revise any of its forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required by law.

Additional Information about the Transaction and Where to Find it

This press release is being made in respect of a proposed business combination involving 4D and Longevity. Following the announcement of the proposed business combination, 4D filed a registration statement on Form F-4 (the Registration Statement) with the SEC, which Registration Statement has been declared effective by the SEC. This press release does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities or a solicitation of any vote or approval nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The Registration Statement includes a preliminary prospectus with respect to 4Ds ordinary shares and ADSs to be issued in the proposed transaction and a proxy statement of Longevity in connection with the merger. The proxy statement/prospectus will be provided to the Longevity shareholders. 4D and Longevity also plan to file other documents with the SEC regarding the proposed transaction.

Participants in the Solicitation

View source version on businesswire.com: https://www.businesswire.com/news/home/20210225005885/en/

More here:
4D Pharma Announces US SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ -...

Posted in Human Longevity | Comments Off

Monthly Archives: March 2021

Hawley calls for breakup of Big Tech ‘oligarchs,’ companies that ‘sold us out to China’ – New York Post

The internet breaks too easily. Can that be fixed? – Christian Science Monitor

More about Big Government than Big Tech – The Hindu

Ageless Review: The Long Run – The Wall Street Journal

Immigration Bill Shows Need To End Employment-Based Immigrant Backlog – Forbes

Anti-Senescence Therapy Market Report Research Reports, Industry Size, In-Depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis…

4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management Team – BioSpace

As Black Women, We Need to Save Ourselves, Not the World – Healthline

Aligning the social pillar with human rights – Social Europe

4D Pharma Announces US SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ -…

The Prometheus League

Breaking News and Updates

Prometheism

Forbidden Fruit

The Evolutionary Perspective

Transtopia Menu

Library Updates

Library Books

Future Euvolution

Lucid Dreams from Childhood

Genetic Revolution

Speciation + Self-Directed Evolution